QuidelOrtho Corporation (0A55.L) Q1 2025 Earnings Report

QuidelOrtho Corporation reported its Q1 2025 results, revealing a revenue of $692.8 million with significant year-over-year and quarter-over-quarter declines. The net income for the quarter was recorded at -$12.7 million, reflecting a substantial decrease of 281.43% year-over-year. Despite these challenges, the company has demonstrated a robust gross profit margin of 93.07%, suggesting effective cost management in its operations. Management emphasized a commitment to innovation and continued investment in research and development, as illustrated by R&D expenses of $53.2 million. These results highlight the ongoing struggles within the healthcare testing market, yet also position QuidelOrtho as a proactive player aiming to leverage emerging opportunities in diagnostic technologies.